American Century Companies
RCUS icon

American Century Companies’s Arcus Biosciences RCUS Stock Holding History

American Century Companies’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-128,947
Closed -$3.07M – 2907
2025
Q4 		$3.07M Buy
128,947
+3,378
+3% +$68.9K ﹤0.01% 1927
2025
Q3 		$1.71M Buy
125,569
+18,517
+17% +$193K ﹤0.01% 2119
2025
Q2 		$871K Buy
107,052
+882
+0.8% +$7.53K ﹤0.01% 2341
2025
Q1 		$833K Buy
106,170
+8,406
+9% +$97.5K ﹤0.01% 2310
2024
Q4 		$1.46M Buy
97,764
+9,782
+11% +$160K ﹤0.01% 2122
2024
Q3 		$1.35M Buy
87,982
+17,065
+24% +$269K ﹤0.01% 2129
2024
Q2 		$1.08M Buy
70,917
+13,019
+22% +$210K ﹤0.01% 2150
2024
Q1 		$1.09M Buy
57,898
+6,139
+12% +$106K ﹤0.01% 2111
2023
Q4 		$989K Sell
51,759
-405,936
-89% -$6.49M ﹤0.01% 2068
2023
Q3 		$8.22M Buy
457,695
+13,373
+3% +$269K 0.01% 1141
2023
Q2 		$9.02M Buy
444,322
+299,685
+207% +$5.71M 0.01% 1100
2023
Q1 		$2.63M Buy
144,637
+13
+0% +$248 ﹤0.01% 1507
2022
Q4 		$2.99M Buy
144,624
+2,224
+2% +$61.2K ﹤0.01% 1429
2022
Q3 		$3.73M Buy
142,400
+33
+0% +$873 ﹤0.01% 1220
2022
Q2 		$3.61M Buy
142,367
+24,652
+21% +$604K ﹤0.01% 1225
2022
Q1 		$3.71M Buy
117,715
+1,911
+2% +$64K ﹤0.01% 1203
2021
Q4 		$4.69M Buy
115,804
+88,904
+330% +$3.45M ﹤0.01% 1078
2021
Q3 		$938K Buy
26,900
+17,776
+195% +$553K ﹤0.01% 1620
2021
Q2 		$251K Sell
9,124
-22,737
-71% -$649K ﹤0.01% 2132
2021
Q1 		$895K Buy
31,861
+12,002
+60% +$418K ﹤0.01% 1479
2020
Q4 		$516K Buy
+19,859
New +$481K ﹤0.01% 1544
2019
Q1 		– Sell
-32,717
Closed -$352K – 1299
2018
Q4 		$352K Buy
+32,717
New +$382K ﹤0.01% 1159

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

American Century Companies's RCUS Position: Q1 2026 in Review

American Century Companies sold out of Arcus Biosciences (RCUS) in Q1 2026, closing a stake of 128,947 shares — an estimated $3.07M sold.

American Century Companies first reported a position in RCUS in Q4 2018 and held it in 22 quarters. The position peaked at $9.02M in Q2 2023. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • American Century Companies reported no remaining Arcus Biosciences position as of Q1 2026 after selling out during the quarter.
  • American Century Companies sold 128,947 Arcus Biosciences shares in Q1 2026, an estimated $3.07M.
  • American Century Companies first reported a position in Arcus Biosciences in Q4 2018 and held it in 22 quarters.
  • American Century Companies's Arcus Biosciences position peaked at $9.02M in Q2 2023.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.